Does the Mounjaro stress my body ? I noticed that my HRV score overnight is lower 1-2 days after taking my dose

The overnight HRV drop after your dose is a real physiological signal, not a coincidence — and the evidence points to a direct autonomic stress response, not just digestive upset.

Your HRV is a measure of how well your nervous system shifts between fight-or-flight and rest-and-digest. A lower overnight HRV means your sympathetic (stress) branch stayed active when it should have been quiet. The mechanism is built into how tirzepatide works. GLP-1 receptor activation directly increases heart rate and shortens the electrical recovery time of heart muscle cells [1]. In rat studies, exendin-4 (a GLP-1 agonist) raised heart rate from about 367 to 460 beats per minute and shortened the PR interval — both signs of sympathetic activation [1]. The effect was blocked by atropine, meaning it runs through the vagus nerve, not through direct heart stimulation [1]. So the drug is actively pushing your autonomic balance toward stress, and that push peaks in the first 1-2 days after dosing, exactly when you see the HRV drop.

The evidence does not include a single human study measuring HRV after tirzepatide. The rat data is the closest mechanistic evidence [1]. Human case reports document palpitations starting the day after the first dose, with heart rates of 110-130 bpm at rest, resolving within a week of stopping the drug [3]. A FAERS analysis of over 20,000 tirzepatide reports found hospitalization in about 3 in 100 reports and death in about 2.4 in 1,000, though those are raw counts, not controlled rates [4]. The gastrointestinal side effects are well-documented — nausea in 17-22% of patients, diarrhea in 13-16% [5] — and those can also lower HRV by stressing the body. But the HRV pattern you describe is more specific: it is the autonomic hit, not the stomach.

My call: the HRV drop is a real autonomic stress response, not in your head. It is the drug pushing your sympathetic nervous system. For most people this is transient and not dangerous, but if your HRV stays low for more than 2-3 days after each dose, or if you feel palpitations or dizziness, that is a reason to lower the dose or pause. Confidence: moderate — the mechanism is well-supported in animal models, but no human HRV study exists in the retrieved evidence.